4th Quarter - Termination

GALILEO CONSULTING GROUP, INC. for AMERICAN UROGYNECOLOGIC SOCIETY

Firm
Client
Income
$10,000
Expenses
—
Terminated
Dec 31, 2024

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FY 2025 Federal Funding for the National Institutes of Health, including National Institute of Child Health and Human Development (NICHD) and the Office of Research on Womens Health - House and Senate Appropriations Committees - FY2025 Continuing Resolution and Other Matters Act (through 3/28/2025) H.R. 9494 and FY2025 Further Continuing Appropriations Act (through 3/14/2025) H.R. 10545.

LobbyistCovered position, as disclosed
JILL RATHBUN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 9494 (118th), H.R. 10545 (118th)

Medicare/Medicaid MMM

Discussions with House and Senate Offices regarding the future of Medicare physician payment and the Medicare physician payment fee schedule, including Dear Colleague letter signers for both House and Senate Letters. FY2025 Continuing Resolution and Other Matters Act (through 3/28/2025) H.R. 9494 and FY2025 Further Continuing Appropriations Act (through 3/14/2025) H.R. 10545.

LobbyistCovered position, as disclosed
JILL RATHBUN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 10545 (118th), H.R. 9494 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.